```html

Yellow‑Green Bacterial Skin Infection (Pseudomonas aeruginosa)

Overview

Pseudomonas aeruginosa is a gram‑negative, rod‑shaped bacterium that thrives in moist environments. When it infects the skin, it often produces a distinctive yellow‑green pigment called pyocyanin, giving the infection its characteristic hue.

Although anyone can develop a Pseudomonas skin infection, the condition is most common among:

• People with compromised immune systems (e.g., cancer patients, organ‑transplant recipients, HIV/AIDS).
• Individuals with chronic wounds or burns.
• Patients who use prolonged catheters, prosthetic devices, or have frequent hospitalizations.
• Those who regularly expose their skin to water that may be contaminated, such as swimmers, hot‑tub users, and people with chronic ear disease.

According to the U.S. CDC, Pseudomonas aeruginosa accounts for about 10–15% of healthcare‑associated infections worldwide, and skin/soft‑tissue infections make up roughly 5% of those cases. While exact community‑acquired rates are harder to pin down, skin infections are the second‑most common manifestation after urinary tract infections.

Symptoms

Symptoms can vary depending on the infection site (e.g., wound, burn, foot ulcer) and the person’s immune status.

• Visible discoloration – A yellow‑green or bluish‑green sheen or pus is the hallmark sign.
• Redness (erythema) – The skin around the affected area becomes inflamed.
• Swelling – Often accompanied by a feeling of warmth.
• Pain or burning sensation – Ranges from mild tenderness to severe throbbing.
• Purulent drainage – Thick, frothy, or watery pus that may have a distinctive odor.
• Fever or chills – More common in systemic spread or when large areas are involved.
• Delayed wound healing – The infection can impede normal tissue repair.
• Skin breakdown or necrosis – In severe cases, the tissue can die, leading to blackened areas.
• Odor – A “fruity” or “musty” smell may be reported, especially in wound exudate.

Causes and Risk Factors

How the infection occurs

Pseudomonas aeruginosa is ubiquitous in soil, fresh water, and especially in moist hospital settings (e.g., sinks, catheters, ventilators). Infection typically begins when the bacteria enter a break in the skin’s protective barrier.

Key risk factors

• Open wounds – burns, cuts, surgical incisions, pressure ulcers.
• Chronic moisture – Prolonged exposure to water, sweating, or wet dressings.
• Immunosuppression – Chemotherapy, corticosteroids, immunosuppressive drugs.
• Diabetes mellitus – Peripheral neuropathy and poor circulation promote infection.
• Hospitalization – Especially in intensive‑care units (ICU) or long‑term care facilities.
• Use of invasive devices – Catheters, central lines, prosthetic joints.
• Prior antibiotic use – Broad‑spectrum antibiotics can disrupt normal flora, allowing Pseudomonas to overgrow.

Diagnosis

Prompt diagnosis is essential because Pseudomonas is often resistant to many standard antibiotics.

Clinical assessment

• Physical exam focusing on lesion color, amount and character of discharge, and surrounding tissue.
• Review of medical history for risk factors and recent exposures.

Laboratory tests

1. Swab culture – A sterile swab of the wound exudate is sent to the lab. Pseudomonas grows rapidly, showing a greenish pigment on specialized media.
2. Quantitative tissue biopsy – For deeper or chronic wounds, a tissue sample may be taken to assess bacterial load.
3. Antibiotic susceptibility testing (AST) – Determines which antibiotics the isolate is sensitive to (essential for guiding therapy).
4. Blood cultures – Ordered if systemic symptoms (fever, chills) suggest bacteremia.

Imaging (if needed)

Ultrasound or MRI can evaluate the extent of deeper tissue involvement, especially when cellulitis or necrotizing fasciitis is suspected.

Treatment Options

Treatment combines antimicrobial therapy, wound care, and addressing underlying risk factors.

Antibiotic therapy

Because Pseudomonas often shows multi‑drug resistance, therapy is usually guided by AST results. Common agents include:

• Anti‑pseudomonal penicillins – Piperacillin‑tazobactam, ticarcillin‑clavulanate.
• Cephalosporins – Ceftazidime, cefepime.
• Carbapenems – Imipenem, meropenem (reserved for resistant strains).
• Aminoglycosides – Gentamicin, amikacin (often used in combination).
• Fluoroquinolones – Ciprofloxacin, levofloxacin (good oral options).
• Polymyxins – Colistin or polymyxin B for extensively drug‑resistant (XDR) isolates.

Typical duration: 7–14 days for uncomplicated infections; longer (up to 4–6 weeks) for chronic wounds or osteomyelitis.

Topical treatments

• Silver‑impregnated dressings – Provide broad antimicrobial activity.
• Topical antibiotics – Gentamicin or mupirocin creams may be used adjunctively.

Procedural interventions

• Debridement – Surgical removal of necrotic tissue improves antibiotic penetration.
• Drainage – For abscess formation, incision and drainage are necessary.
• Negative‑pressure wound therapy (NPWT) – Enhances granulation and reduces edema.

Lifestyle and supportive measures

• Elevate affected limbs to decrease swelling.
• Maintain optimal nutrition (protein ≥ 1.2 g/kg/day) to support healing.
• Control blood glucose in diabetic patients.
• Avoid tight or occlusive dressings that keep skin moist.

Living with Yellow‑Green Bacterial Skin Infection (Pseudomonas aeruginosa)

Managing a Pseudomonas skin infection is a partnership between you, your healthcare team, and your daily habits.

Daily wound care checklist

1. Wash hands thoroughly with soap and water before and after touching the wound.
2. Change dressings as instructed (usually every 24–48 hours).
3. Inspect the wound for new discoloration, increased drainage, or foul odor.
4. Keep the area dry; use a moisture‑wicking bandage if you sweat a lot.
5. Document any changes (size, color, pain level) in a simple log to share with your clinician.

Self‑monitoring tips

• Track temperature twice daily; a fever ≥ 100.4 °F (38 °C) warrants a call.
• Note any spreading redness beyond the original margins.
• Pay attention to increased pain that is “out of proportion” to the wound.

Psychosocial considerations

Chronic skin infections can affect self‑esteem and daily activities. Consider:

• Joining support groups for patients with chronic wounds.
• Discussing pain management options with your provider.
• Seeking counseling if infection‑related stress impacts mental health.

Prevention

Because Pseudomonas loves moisture, keeping skin dry and clean is the cornerstone of prevention.

• Proper wound hygiene – Clean wounds with saline, avoid harsh antiseptics that delay healing.
• Change dressings promptly – Use breathable, non‑occlusive materials.
• Protective footwear – Wear water‑resistant shoes in public pools, hot tubs, or when walking in moist environments.
• Catheter care – Follow sterile insertion techniques and replace catheters as recommended.
• Hand hygiene – Wash hands with soap for at least 20 seconds; use alcohol‑based sanitizer when soap isn’t available.
• Limit unnecessary antibiotic use – Discuss with your doctor before starting broad‑spectrum antibiotics.
• Control chronic conditions – Keep diabetes, peripheral vascular disease, and immune‑modulating conditions optimally managed.

Complications

If left untreated or inadequately treated, Pseudomonas skin infections can progress to serious complications:

• Cellulitis & spreading infection – Can involve deeper fascia or muscle.
• Necrotizing fasciitis – A rapidly progressive, life‑threatening soft‑tissue destruction.
• Osteomyelitis – Bone infection, especially in diabetics with foot ulcers.
• Septicemia (bloodstream infection) – May lead to sepsis, multi‑organ failure.
• Scarring and contractures – Permanent skin loss or limited joint movement.
• Antibiotic resistance – Inadequate treatment can select for multidrug‑resistant strains.

When to Seek Emergency Care

---

References:

• Mayo Clinic. “Pseudomonas infection.” https://www.mayoclinic.org
• Centers for Disease Control and Prevention. “Pseudomonas aeruginosa.” https://www.cdc.gov
• National Institutes of Health. “Antibiotic Treatment of Pseudomonas Skin Infections.” NIH Clinical Guidelines.
• Cleveland Clinic. “Wound Care & Prevention of Infection.” https://my.clevelandclinic.org
• World Health Organization. “Antimicrobial resistance.” https://www.who.int

```